Piramal Pharma Limited at a Glance
Piramal Pharma Limited is a global pharma company committed to advancing healthcare through high-quality, science-led products and services. As a trusted name in the pharmaceutical industry, piramal pharma partners with customers and consumers worldwide to deliver innovative, reliable, and compliant products and services that improve patient outcomes.
Piramal Pharma operates state-of-the-art facilities that support end-to-end pharmaceutical development and manufacturing across the drug development lifecycle. The company follows stringent global quality and regulatory standards, ensuring consistency, safety, and efficacy in every product.
The company combines deep scientific expertise with advanced technologies to support complex formulations and specialized therapies.
Guided by a purpose of Doing well & Doing Good, piramal pharma continues to deliver sustainable growth through ethical practices, and patient-centric solutions. Through continuous innovation and a commitment to quality, the company remains a trusted partner for customers, consumers, patients, and stakeholders across the global healthcare ecosystem.
Businesses
Pharma Solutions
Piramal Pharma Solutions (PPS) is a Contract Development and Manufacturing Organization (CDMO) offering end-to-end development and manufacturing solutions across the drug life cycle, serving customers through a globally integrated network of facilities in North America, Europe, and Asia.
Critical Care
Piramal Critical Care (PCC) is a leading, global player in inhaled anesthetics hospital generics, maintaining a wide presence across the USA, Europe and more than 100 countries worldwide.
Consumer Healthcare
Piramal Consumer Healthcare (PCH) is one of the fastest-growing businesses of Piramal Pharma Limited. It is among the leading players in the Indian self-care space, with established brands like Littles, Lacto Calamine, i-pill, Tetmosol. Polycrol and Tri-Activ, among others, in the Indian Consumer Healthcare market.
AbbVie Therapeutics India Private Limited
AbbVie Therapeutics India Private Limited (formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and Piramal Pharma Limited, commenced commercial operations in 1996 and has emerged as the market leader in the fast-growing ophthalmic category with the successful launches of a series of high technology medication and devices for diseases such as glaucoma, dry eye, infections, and inflammations.
Latest At Piramal Pharma
Blogs
17.06.2026
How Pharmaceutical Manufacturing Supports the Production of Highly Potent Drugs
The pharmaceutical industry is witnessing a significant shift toward highly potent therapies driven by advances in precision medicine and targeted treatment approaches. A potent drug in pharmaceuticals delivers therapeutic efficacy at extremely low dosage levels, enabling improved outcomes while minimizing systemic exposure.
Read More
08.06.2026
Regulatory Challenges in Pharma Development Across US, UK & Canada
Regulatory Challenges in Pharma Development Across US, UK & Canada
Read More
08.06.2026
GMP Guidelines in the US, UK and Canada: What You Need to Know
Pharmaceutical manufacturing operates under some of the most rigorous standards in any industry. Whether a facility is producing active pharmaceutical ingredients (APIs), finished dosage forms, or packaging finished drugs, every step must meet defined quality benchmarks.
Read More